The American Headache Society Position Statement On Integrating New Migraine Treatments Into Clinical Practice

This position statement offers healthcare professionals updated guidance on migraine treatments. It focuses on integrating new preventive and acute therapies for adults. Recent developments in technologies and treatments necessitate this updated guidance. The statement reviews existing guidelines and recent clinical trial results. Input was gathered from various stakeholders, including healthcare providers and patients. Expert clinicians from North America and the European Union contributed their insights. The principles for preventive treatment emphasize evidence-based approaches and gradual dose increases. It’s important to establish therapeutic expectations and maximize patient adherence. New injectable treatments may provide faster relief without the need for titration. For acute treatment, early intervention and nonoral routes are recommended. Patients should also consider self-administered rescue options. Neuromodulation and biobehavioral therapy are viable alternatives for some patients. This updated guidance aims to enhance treatment efficacy and patient care in migraine management. Clinical relevance: This research emphasizes integrating new migraine treatments to optimize patient care and outcomes.